Mengxia Li

5.2k citations
187 papers · 4.1k · 2 hit papers · h-index 31

Impact in

  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • DNA Repair Mechanisms
    • Advanced biosensing and bioanalysis techniques
    • Redox biology and oxidative stress

Papers in

Mengxia Li

180 papers receiving 4k citations

Mengxia Li's Hit Papers

Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant 2024 · 119 citations
1190+1+2Years since publication100200300

Peers

Mengxia Li
Comparison fields: 5 of 116
  • Oncology 563
  • Molecular Biology 1.2k
  • Cancer Research 262
  • Drug Discovery 5
  • Toxicology 82
Replace Sui Zhang with:
Sui Zhang United States
Ansar Karimian Iran
Peng Chen China
Christiane Chéreau France
Stan G. Louie United States
Huei‐Wen Chen Taiwan
Bernard J. Weill France
Po‐Li Wei Taiwan
Yuan Li Shen China
Mengxia Li relative to Sui Zhang United States Sui Zhang's profile →
Citations per field
00.5×1.5×2×2.5×
Sui Zhang · 1×
Citations per year

Countries citing papers authored by Mengxia Li

Since Specialization
Citations

This map shows the geographic impact of Mengxia Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengxia Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengxia Li more than expected).

Fields of papers citing papers by Mengxia Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengxia Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengxia Li. The network helps show where Mengxia Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Mengxia Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mengxia Li Line = papers co-authored together Mengxia Li links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 187 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial
Hit paper breakdown →
2022371
2 2013225
3 2011121
4
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant
Hit paper breakdown →
2024119
5 2017106
6 2018102
7 200598
8 202188
9 201083
10 201680
11 201477
12 201775
13 200866
14 201159
15 201859
16 201358
17 201456
18 202154
19 201443
20 202243

About Mengxia Li

Mengxia Li is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Animal Science and Zoology, having authored 187 papers that have together received 4.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (14 papers), DNA Repair Mechanisms (13 papers), Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Research Studies (10 papers), Animal Virus Infections Studies (8 papers), Nanoparticle-Based Drug Delivery (8 papers), Angiogenesis and VEGF in Cancer (6 papers) and Epigenetics and DNA Methylation (6 papers). The work is most often cited by research in Oncology (563 citations), Molecular Biology (1.2k citations), Cancer Research (262 citations), Drug Discovery (5 citations) and Toxicology (82 citations). Mengxia Li has collaborated with scholars based in China, United States and Germany. Frequent co-authors include David M. Wilson, Dong Wang, Nan Dai, Henning Neubauer, Zhaoyang Zhong, Yi Qing, Shiheng Zhang, Weihua Zhu, Xiaojuan Xu and Yan Li Cao. Their work appears in journals such as Cancer Science, Frontiers in Oncology, Clinical Epigenetics, Scientific Reports and Cell Biochemistry and Biophysics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact